We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combining Multiple Laboratory Techniques Provides Deeper Insights into Deadly Brain Tumors

By LabMedica International staff writers
Posted on 15 May 2025

Glioblastoma (GBM) is a highly aggressive primary brain cancer that currently has limited effective treatments. More...

Stereotactic needle biopsies are commonly employed for diagnosis; however, their use is restricted as physicians typically limit the collection of small tumor samples due to the invasive nature of the procedure, which requires sedation with anesthesia. Tumor samples are usually obtained at the start of treatment and, occasionally, at the end. In a groundbreaking study, a team of researchers has shown that doctors can gather extensive information about a patient’s cancer by applying various laboratory techniques to analyze tumor tissue obtained from needle biopsies of glioblastoma. This work, published in Nature Communications, could also have significant implications for diagnosing and studying other types of cancer.

In the study, clinicians from Johns Hopkins Kimmel Cancer Center (Baltimore, MD, USA) and four other institutions injected a virus designed to target and kill glioblastoma cells directly into the tumor. During the same procedure, surgeons collected tumor tissue samples, which were then analyzed using multiple advanced laboratory techniques, including single-cell RNA sequencing, transcriptomics, metabolomics, proteomics, and immune profiling. These techniques allowed the researchers to demonstrate that even small samples of tumor tissue could provide valuable insights into the tumor's biological characteristics, immune interactions, and molecular pathways. Additionally, the study found that the tissue could be grafted onto a mouse model for further examination and analysis.

“This is a concept that expands beyond just brain cancers,” said study co-author Chetan Bettegowda, M.D., Ph.D. “Whenever people do needle biopsies, it has been just sufficient to study if the tissue is cancerous, what type and maybe some very simple molecular characterization. This brings tissue analysis to the modern age. ... Historically [oncologists] haven’t done repeat biopsies because we felt, ‘Oh, what are we going to get that we don’t already know from the original diagnosis?’ It turns out there’s quite a bit to be learned.”

Related Links:
Johns Hopkins Kimmel Cancer Center


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.